ASCLETIS-B (01672) spent approximately HK$4.3738 million on repurchasing 300,000 shares on December 12th.
Galepharmaceutical-B(01672) announced that on December 12, 2025, it will spend approximately 4.3738 million Hong Kong dollars to repurchase 300,000 shares.
ASCLETIS-B (01672) announced that on December 12, 2025, it has spent approximately 4.3738 million Hong Kong dollars to repurchase 300,000 shares.
Related Articles
On December 12, JXR (01951) spent 19.3521 million Hong Kong dollars to buy back 7.722 million shares.
Jiangsu Hengrui Pharmaceuticals (01276): HRS-1780 tablets receive approval notice for drug clinical trials.
Shennan Circuits (002916.SZ) plans to grant 15.16 million restricted shares.
On December 12, JXR (01951) spent 19.3521 million Hong Kong dollars to buy back 7.722 million shares.
Jiangsu Hengrui Pharmaceuticals (01276): HRS-1780 tablets receive approval notice for drug clinical trials.
Shennan Circuits (002916.SZ) plans to grant 15.16 million restricted shares.
